Pathophysiological roles of DUX4 in FSHD1 (Homo sapiens)
From WikiPathways
Description
The transcription factor DUX4 is normally expressed during the 4-cell stage, activating various pathways leading to cleavage. This pathway shows how the abberrant expression of DUX4 in post-embryonic stages leads to several disturbations in skeletal muscle fibers, leading to adverse outcomes such as inflammation and apoptosis.
Quality Tags
Ontology Terms
Bibliography
View all... |
- Imamachi N, Tani H, Akimitsu N; ''Up-frameshift protein 1 (UPF1): multitalented entertainer in RNA decay.''; Drug Discov Ther, 2012 PubMed Europe PMC Scholia
- Xu, H., Wang, Z., Jin, S., Hao, H., Zheng, L., Zhou, B., Zhang, W., Lv, H., Yuan, Y.; ''Dux4 induces cell cycle arrest at G1 phase through upregulation of p21 expression''; https://doi.org/10.1016/j.bbrc.2014.02.105, 2014 PubMed Europe PMC Scholia
- Teresa Schätzl, Lars Kaiser, Hans-Peter Deigner; ''Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update''; , 2021 PubMed Europe PMC Scholia
- Zoltan Arany, Shi-Yin Foo, Yanhong Ma, Jorge L Ruas, Archana Bommi-Reddy, Geoffrey Girnun, Marcus Cooper, Dina Laznik, Jessica Chinsomboon, Shamina M Rangwala, Kwan Hyuck Baek, Anthony Rosenzweig, Bruce M Spiegelman; ''HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha''; , 2008 PubMed Europe PMC Scholia
- Block GJ, Narayanan D, Amell AM, Petek LM, Davidson KC, Bird TD, Tawil R, Moon RT, Miller DG; ''Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells.''; Hum Mol Genet, 2013 PubMed Europe PMC Scholia
- Mul K, Horlings CGC, Voermans NC, Schreuder THA, van Engelen BGM; ''Lifetime endogenous estrogen exposure and disease severity in female patients with facioscapulohumeral muscular dystrophy.''; Neuromuscul Disord, 2018 PubMed Europe PMC Scholia
- Kenji Rowel Q. Lim, Quynh Nguyen, Toshifumi Yokota; ''DUX4 Signalling in the Pathogenesis of Facioscapulohumeral Muscular Dystrophy''; , 2020 PubMed Europe PMC Scholia
- Teveroni E, Pellegrino M, Sacconi S, Calandra P, Cascino I, Farioli-Vecchioli S, Puma A, Garibaldi M, Morosetti R, Tasca G, Ricci E, Trevisan CP, Galluzzi G, Pontecorvi A, Crescenzi M, Deidda G, Moretti F; ''Estrogens enhance myoblast differentiation in facioscapulohumeral muscular dystrophy by antagonizing DUX4 activity.''; J Clin Invest, 2017 PubMed Europe PMC Scholia
- Lagirand-Cantaloube J, Cornille K, Csibi A, Batonnet-Pichon S, Leibovitch MP, Leibovitch SA; ''Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo.''; PLoS One, 2009 PubMed Europe PMC Scholia
- Fiorini F, Bagchi D, Le Hir H, Croquette V; ''Human Upf1 is a highly processive RNA helicase and translocase with RNP remodelling activities.''; Nat Commun, 2015 PubMed Europe PMC Scholia
- Oliva, J., Galasinski, S., Richey, A., Campbell, AE., Meyers, M. J., Modi, N., Zhong, J. W., Tawil, R., Tapscott, S. J., Sverdrup, F. M; ''Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy''; 10.1124/jpet.119.259663, 2019 PubMed Europe PMC Scholia
- Shadle, S.C., Zhong, J.W., Campbell, A.E., Conerly, M.L., Jagannathan, S.; ''DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy''; PLOS Genetics, 2017
- Bosnakovski, D., Gearhart, M.D., Toso, E.A.; ''Low level DUX4 expression disrupts myogenesis through deregulation of myogenic gene expression.''; Sci Rep, 2018
- Vanderplanck C, Ansseau E, Charron S, Stricwant N, Tassin A, Laoudj-Chenivesse D, Wilton SD, Coppée F, Belayew A; ''The FSHD atrophic myotube phenotype is caused by DUX4 expression.''; PLoS One, 2011 PubMed Europe PMC Scholia
- Bosnakovski D, Toso EA, Hartweck LM, Magli A, Lee HA, Thompson ER, Dandapat A, Perlingeiro RCR, Kyba M; ''The DUX4 homeodomains mediate inhibition of myogenesis and are functionally exchangeable with the Pax7 homeodomain.''; J Cell Sci, 2017 PubMed Europe PMC Scholia
- Knopp P, Krom YD, Banerji CR, Panamarova M, Moyle LA, den Hamer B, van der Maarel SM, Zammit PS; ''DUX4 induces a transcriptome more characteristic of a less-differentiated cell state and inhibits myogenesis.''; J Cell Sci, 2016 PubMed Europe PMC Scholia
- Bosnakovski, D., Gearhart, M.D., Toso, E.A.; ''Low level DUX4 expression disrupts myogenesis through deregulation of myogenic gene expression''; Nature, 2018
- Shadle, S.C., Zhong, J.W., Campbell, A.E., Conerly, M.L., Jagannathan, S.; ''DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy''; Plos Genetics, 2017
- Banerji CR, Knopp P, Moyle LA, Severini S, Orrell RW, Teschendorff AE, Zammit PS; ''β-Catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy.''; J R Soc Interface, 2015 PubMed Europe PMC Scholia
- Resnick, R, Wong, C.J., Hamm, D.C., Bennett, S.R., Skene, P.J., Hake, S.B., Henikoff, S.J.; ''DUX4-Induced Histone Variants H3.X and H3.Y Mark DUX4 Target Genes for Expression''; https://pubmed.ncbi.nlm.nih.gov/31722199/, 2019 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
ADRB2 | GeneProduct | 154 (Entrez Gene) | |
BMP pathway | Pathway | WP211 (WikiPathways) | |
CDKN1A | GeneProduct | 1026 (Entrez Gene) | |
DUX4 | GeneProduct | 100288687 (Entrez Gene) | |
E2 | Metabolite | CHEBI:23965 (ChEBI) | |
ESR2 | GeneProduct | 2100 (Entrez Gene) | |
H3.X | GeneProduct | ENSG00000268799 (Ensembl) | |
H3.Y | GeneProduct | ENSG00000269466 (Ensembl) | |
JNK pathway | Pathway | WP1047 (WikiPathways) | |
MAFbx | GeneProduct | 114907 (Entrez Gene) | |
MURF1 | GeneProduct | 84676 (Entrez Gene) | |
MYC | GeneProduct | 4609 (Entrez Gene) | |
MYF5 | GeneProduct | 4617 (Entrez Gene) | |
MYOD1 | GeneProduct | 4654 (Entrez Gene) | |
MYOG | GeneProduct | 4656 (Entrez Gene) | |
P300 | GeneProduct | 2033 (Entrez Gene) | |
P53 pathway | Pathway | WP2902 (WikiPathways) | |
PAX7 | GeneProduct | ENSG00000009709 (Ensembl) | |
PGC1A | GeneProduct | 10891 (Entrez Gene) | |
RET | GeneProduct | 5979 (Entrez Gene) | |
TNF-A pathway | Pathway | WP1047 (WikiPathways) | |
UPF1 | GeneProduct | 5976 (Entrez Gene) | |
Unknown | |||
VEGFA | GeneProduct | 7422 (Entrez Gene) | |
Wnt signaling | Pathway | WP428 (WikiPathways) | |
cAMP | Metabolite | CHEBI:17489 (ChEBI) | |
p38 MAPK pathway | Pathway | WP400 (WikiPathways) |
Annotated Interactions
No annotated interactions